跳至主要内容
临床试验/NCT04372355
NCT04372355已完成2 期

Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Srinakharinwirot University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年6月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
HbA1c change at Week 8 in comparison to Baseline

研究概览

简要总结

Study in adult Diabetes Mellitus patients with diabetic foot ulcers and elevated HbA1c who will receive standard wound treatment in combination with adjuvant therapy WF10 to compare the change of HbA1c levels at baseline and after treatment.

详细描述

Single-center, Prospective Open-labelled One Group Pretest Posttest Pilot Study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with Diabetes Mellitus type II
  • Patient male or female 18-80 years old
  • Presence of Diabetic foot ulcer/non-healed stump, starting at least 3 weeks before or infected wound degree 3-4
  • HbA1c > 8.5%
  • Hematocrit > 30%

排除标准

  • Kanofsky performance status < 60
  • Patient with ABI (Ankle Brachial index) < 0.4
  • Patient who receive steroid ,chemotherapeutic drug
  • Pregnant or lactating woman
  • Patient had a history of organ transplantation, and using immunosuppressive drug
  • Patient with end-stage renal disease requiring hemodialysis, or history of G6PD or severe thalassemia, or ischemic heart disease, Congestive heart failure, Heart arrhythmia
  • Patient who is participating in another clinical study or have done it in the past 30 days.

研究组 & 干预措施

Chlorite-based drug WF10

Experimental

WF10, the chlorite-based drug is infused at a dose of 0.3 ml/Kg BW, after dilution in 300 mL physiological saline, over a period of 3 h. The drug is applied once a week for five

干预措施: WF10 (Drug)

结局指标

主要结局

HbA1c change at Week 8 in comparison to Baseline

时间窗: 8 weeks

The mean change of HbA1c values between Baseline (Week 0) and Week 8 after the initial WF10 treatment

次要结局

  • HbA1c change at Week 12 in comparison to Baseline(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Narongchai Yingsakmongkol

Associate Professor

Srinakharinwirot University

研究点 (1)

Loading locations...

相似试验